Federal Supply Schedule GS24F0019M
Award Date 2/15/02
Last Date to Order 12/24/03
Funding Federal Agency
Not listed Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 to Exact Sciences Corporation, a for-profit medical technology company. The BPA, valued at $4,000,000, is established under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule and has an ultimate completion date of August 17, 2028. The primary purpose of this contract is to provide Oncotype DX cancer...
- The federal contract IDV award is a single-award Blanket Purchase Agreement (BPA) issued by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 19 (VISN 19) to MDXHealth, Inc., a for-profit healthcare company specializing in molecular diagnostic services for cancer testing and analysis. The $1,424,021.22 BPA, awarded on October 1, 2025 with a performance period through September 30, 2030, enables VISN 19 to efficiently procure MDXHealth's specialized cancer diagnostic...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Mdxhealth, Inc., a for-profit healthcare company, for the provision of specialized cancer diagnostic testing services. The BPA is under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract (FSS-621-II) and has a total potential value of $280,000 with an ultimate completion date of April 2, 2029. Specifically, the BPA covers DX Prostate Testing,...
- The Department of Veterans Affairs (VA) has awarded Biodesix, Inc., a for-profit medical laboratory and diagnostic testing company based in Boulder, Colorado, a $20.3 million multiple-award Federal Supply Schedule contract for medical laboratory testing and analysis services. This contract enables VA medical centers to issue task orders for Biodesix's specialized lung testing capabilities, including Nodify lung blood testing, STX lung cancer screening, and other diagnostic testing options....
- The Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 22 awarded a single-award Blanket Purchase Agreement (BPA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype genetic testing services. The BPA has a ceiling value of $970,352 and a period of performance from February 2023 through February 2028. Under this IDV, the VA can order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis at...
- This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to Mdxhealth, Inc., a for-profit healthcare company specializing in cancer diagnostics. The BPA, with a total ceiling value of $4,800,000, is for the provision of Oncotype DX prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. The period of performance...
- This Blanket Purchase Agreement (BPA) is a single-award federal contract vehicle administered by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to procure cancer diagnostic testing services from MdxHealth, Inc., a for-profit healthcare company. The BPA calls for MdxHealth to provide its MDXHEALTH GPS molecular diagnostic services, which utilize genetic and epigenetic biomarkers to support personalized diagnosis and treatment for various cancers...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) to Exact Sciences Corporation, a for-profit medical technology company. The contract, valued at $919,774.30, is for the provision of Genomic Health genetic testing services, primarily the Oncotype DX gene expression profiling test, to VISN 19 healthcare facilities. The contract utilizes the Medical Laboratory Testing and Analysis Services (FSS-621-II)...
- The federal contract IDV award to Veracyte, Inc. under the GSA's Medical Laboratory Testing and Analysis Services Schedule (FSS-621-II) enables multiple federal agencies, including the Department of Veterans Affairs (VA) and Defense Health Agency, to procure Veracyte's genomic testing services. The contract, valued at up to $2.3 million through July 2028, provides access to Veracyte's commercial laboratory capabilities for cancer screening and diagnosis, such as the Afirma Genomic Sequencing...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Veterans Health Administration (VHA) to Exact Sciences Corporation, through its Exact Sciences Laboratories, LLC division. The BPA has a total ceiling value of $335,800 and is for the provision of Oncotype DX cancer testing services, including gene expression profiling and genomic testing, to support federal healthcare programs. The contract utilizes Exact Sciences' Federal Supply...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order GS24F0019M-00508200203C5082A5016GS24F0019M | Biotheranostics Inc. | $0 | 3/15/02 | 4/15/02 | 3/15/02 | |
Delivery Order GS24F0019M-00506200306C506P3A787GS24F0019M | Biotheranostics Inc. | $0 | 6/15/03 | 6/15/03 | 6/15/03 | |
Delivery Order GS24F0019M-00261200204C263FQ209860GS24F0019M | Biotheranostics Inc. | $0 | 4/15/02 | 2/15/07 | 4/15/02 | |
Delivery Order GS24F0019M-00263200209C263FD217689GS24F0019M | Biotheranostics Inc. | $0 | 9/15/02 | 11/15/02 | 9/15/02 | |
Delivery Order GS24F0019M-DABJ0503F0381 | Biotheranostics Inc. | $0 | 6/30/03 | 8/31/03 | 6/30/03 |